March 09, 2026 - PRESSADVANTAGE - Chiropractor Evansville has released an announcement outlining its approach to back ...

Paolo Vanoli admits Fiorentina have regressed in the last couple of weeks after a 0-0 draw with Parma and gives a Moise Kean injury update. ‘It’ll be a battle to the end.’It should’ve been a ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...

Did you know that back pain and herniated discs are among the most common causes of spine discomfort and reduced mobility, often leading patients to consider surgical intervention?

Lower back pain in women often results from hormone changes, pregnancy, or gynecological conditions. Fever, unexplained weight loss, and pain that lasts longer than a few weeks warrant a doctor's ...

The MarketWatch News Department was not involved in the creation of this content.-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which ...

Jakob Roze, CSCS, is a health writer and high-end personal trainer. He is the founder and CEO of RozeFit, a high-end concierge personal training practice and online blog. The downward dogs and cat-cow ...

Duty belts cause real, documented physical harm to law enforcement officers. Research indicates that 60% of law enforcement officers experience low back pain, with the duty belt commonly reported as a ...

If you have yet to experience back pain, the odds are sadly stacked against you. According to World Health Organization data, most people will experience low back pain at some point in their lives.

Dana Santas, known as the “Mobility Maker,” is a certified strength and conditioning specialist and mind-body coach in professional sports, and is the author of the book “Practical Solutions for Back ...

Turmeric is a spice with antioxidant and anti-inflammatory properties. It may help to treat various types of pain, including joint, muscle, and nerve pain.

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced debut data from its Phase 3 ALLEVIATE-1 and ALLEVIATE-2 studies evaluating the safety and efficacy of ...